Reborna is a next-generation biotech pioneering RNA-targeted small molecule therapeutics to unlock disease mechanisms beyond the reach of conventional drug discovery
Reborna is a next-generation biotech pioneering RNA-targeted small molecule therapeutics to unlock disease mechanisms beyond the reach of conventional drug discovery. Our core technology, RNA Insight, enables screening against full-length mRNA and mini-genes—a fundamentally different approach from conventional fragment-based methods.